Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients

INTRODUCTION: Cytokines produced by B cells are believed to play important roles in autoimmune diseases. CD22 targeting by epratuzumab has been demonstrated to inhibit phosphorylation of B cell receptor (BCR) downstream signaling in B cells. It has been shown that other sialoadhesin molecules relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischer, Vanessa, Sieber, Julia, Fleischer, Sarah J., Shock, Anthony, Heine, Guido, Daridon, Capucine, Dörner, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504352/
https://www.ncbi.nlm.nih.gov/pubmed/26183319
http://dx.doi.org/10.1186/s13075-015-0686-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504352/
https://www.ncbi.nlm.nih.gov/pubmed/26183319
http://dx.doi.org/10.1186/s13075-015-0686-2

Ejemplares similares